About CHA Meditech
Chameditech cosmetic lab, located in Seongnam-si, Gyeonggi-do, operates a state-of-the-art biopilot plant facility in South Korea. Since 2013, this CHA Biotech spin-off has developed:
- Growth factors and peptides using genetic engineering
- Hyaluronic acid cross-linking technology
- Medical devices with anti-adhesion properties
- Dermal fillers for cosmetic applications
With MFDS GMP and European ISO certifications, Chameditech maintains international research partnerships from its 300L biopharmaceutical manufacturing facility.
Frequently asked questions
Chameditech provides the following biopharmaceutical products and services:
- Growth Factor Production
- EGF (Epidermal Growth Factor)
- bFGF (Basic Fibroblast Growth Factor)
- GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor)
- VEGF (Vascular Endothelial Growth Factor)
- Medical Device Development
- Dermal fillers
- Anti-adhesion devices
- Hyaluronic acid products
- Manufacturing Services
- 300L Biopilot plant operations
- Biological pharmaceutical production
- Peptide synthesis
Chameditech maintains the following technological and regulatory standards:
| Category | Details |
|---|---|
| Core Technologies |
|
| Quality Systems |
|
| Research Capabilities |
|
Chameditech operates from its facilities in Korea with the following infrastructure:
- Production Facilities
- 300L Biopilot manufacturing plant
- GMP-certified production areas
- Quality control laboratories
- Research Centers
- Biotechnology research labs
- Product development facilities
- Testing laboratories
The company maintains international research partnerships and serves global markets through:
- Joint research programs
- Technology transfer agreements
- Distribution networks
More details about CHA Meditech
A leading biotech company in South Korea
Chameditech, established in 2013, emerged from CHA Biotech’s medical device division to become a specialized cosmetic lab and biopharmaceutical company in Seongnam-si, South Korea.
Advanced biotechnology solutions
Operating from the technology hub of Gyeonggi-do, Chameditech leverages genetic engineering to develop and produce growth factors, peptides, and natural extracts. The company’s expertise extends to EGF, bFGF, GM-CSF, and VEGF production.
Innovation in dermal solutions
The company has developed proprietary hyaluronic acid cross-linking technology, advancing the field of dermal fillers and medical devices. This technology serves both cosmetic and medical applications.
Quality and manufacturing excellence
Chameditech maintains high production standards through:
- MFDS GMP certification from Korea
- European ISO certification
- 300L Biopilot Plant facility
Research and international collaboration
Based in Seongnam-si’s biotechnology district, Chameditech actively participates in joint research with international scientists. This collaboration focuses on biopharmaceutical development and innovative medical solutions.
Manufacturing capabilities
The company’s state-of-the-art facility in Gyeonggi-do includes a modern biopilot plant for pharmaceutical manufacturing, supporting both research and production needs.
Company gallery
